U.S. Immunoassay Market (2024 - 2030) Size, Share & Trends Analysis Report By Product (Reagent & Kits, Analyzers/Instruments), By Technology (RIA, ELISA), By Application, By Specimen, By End-use, By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product
                        1.2.2. Technology
                        1.2.3. Application
                        1.2.4. End-use
                        1.2.5. Specimen
                        1.2.6. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Volume price analysis (Model 2)
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product outlook
                        2.2.2. Technology outlook
                        2.2.3. Application outlook
                        2.2.4. End-use outlook
                        2.2.5. Specimen outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Immunoassay Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                        3.2.2. Market restraint analysis
                    3.3. U.S. Immunoassay Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                           3.3.1.1. Supplier power
                           3.3.1.2. Buyer power
                           3.3.1.3. Substitution threat
                           3.3.1.4. Threat of new entrant
                           3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Economic landscape
                           3.3.2.3. Social landscape
                           3.3.2.4. Technological landscape
                           3.3.2.5. Legal landscape
                           3.3.2.6. Environmental landscape
Chapter 4. U.S. Immunoassay Market: Product Estimates & Trend Analysis
                    4.1. Product Market Share, 2023 & 2030
                    4.2. Segment Dashboard
                    4.3. U.S. Immunoassay Market by Product Outlook
                    4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
                        4.4.1. Reagents & kits
                            4.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                            4.4.1.2. ELISA reagents & kits
                                4.4.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                             4.4.1.3. Rapid test reagents & kits
                                4.4.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                             4.4.1.4. ELISPOT reagents & kits
                                4.4.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                             4.4.1.5. Western blot reagents & kits
                                4.4.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                             4.4.1.6. Other reagents & kits
                                4.4.1.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                         4.4.2. Analyzers/instruments
                             4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                             4.4.2.2. Open ended systems
                                4.4.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                            4.4.2.3. Closed ended systems
                                4.4.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                         4.4.3. Software & Services
                            4.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. U.S. Immunoassay Market: Technology Estimates & Trend Analysis
                    5.1. Technology Market Share, 2023 & 2030
                    5.2. Segment Dashboard
                    5.3. U.S. Immunoassay Market by Technology Outlook
                    5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
                        5.4.1. Radioimmunoassay (RIA)
                            5.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        5.4.2. Enzyme Immunoassays (EIA)
                            5.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                            5.4.2.2. Chemiluminescence Immunoassays (CLIA)
                                5.4.2.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                            5.4.2.3. Fluorescence Immunoassays (FIA)
                                5.4.2.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        5.4.3. Rapid test
                            5.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        5.4.4. Others
                            5.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. U.S. Immunoassay Market: Application Estimates & Trend Analysis
                    6.1. Application Market Share, 2023 & 2030
                    6.2. Segment Dashboard
                    6.3. U.S. Immunoassay Market by Application Outlook
                    6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
                        6.4.1. Therapeutic drug monitoring
                            6.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        6.4.2. Oncology
                            6.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        6.4.3. Cardiology
                            6.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        6.4.4. Endocrinology
                            6.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        6.4.5. Infectious disease testing
                            6.4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        6.4.6. Autoimmune diseases
                            6.4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        6.4.7. Others
                            6.4.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. U.S. Immunoassay Market: End-use Estimates & Trend Analysis
                    7.1. End-use Market Share, 2023 & 2030
                    7.2. Segment Dashboard
                    7.3. U.S. Immunoassay Market by End-use Outlook
                    7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
                        7.4.1. Hospitals
                            7.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.4.2. Blood banks
                            7.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.4.3. Clinical laboratories
                            7.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.4.4. Pharmaceutical and biotech companies
                            7.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.4.5. Academic research centers
                            7.4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        7.4.6. Others
                            7.4.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. U.S. Immunoassay Market: Specimen Estimates & Trend Analysis
                    8.1. Specimen Market Share, 2023 & 2030
                    8.2. Segment Dashboard
                    8.3. U.S. Immunoassay Market by Specimen Outlook
                    8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
                        8.4.1. Blood
                            8.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        8.4.2. Saliva
                            8.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        8.4.3. Urine
                            8.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        8.4.4. Other specimens
                            8.4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 9. U.S. Immunoassay Market: Region Estimates & Trend Analysis
                    9.1. Regional Market Share, 2023 & 2030
                    9.2. U.S. Immunoassay Market by Region Outlook
                    9.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
                        9.3.1. West
                            9.3.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        9.3.2. Midwest
                            9.3.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        9.3.3. Northeast
                            9.3.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        9.3.4. Southwest
                            9.3.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
                        9.3.5. Southeast
                            9.3.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 10. Competitive Landscape
                    10.1. Recent Developments & Impact Analysis, By Key Market Participants
                    10.2. Company/Competition Categorization
                    10.3. Vendor Landscape
                        10.3.1. List of key distributors and channel partners
                        10.3.2. Key customers
                        10.3.3. Key company heat map analysis, 2023
                    10.4. Company Profiles
                        10.4.1. F. Hoffmann-La Roche AG
                            10.4.1.1. Company overview
                            10.4.1.2. Financial performance
                            10.4.1.3. Product benchmarking
                            10.4.1.4. Strategic initiatives
                        10.4.2. Abbott Laboratories
                            10.4.2.1. Company overview
                            10.4.2.2. Financial performance
                            10.4.2.3. Product benchmarking
                            10.4.2.4. Strategic initiatives
                        10.4.3. Siemens Healthineers
                            10.4.3.1. Company overview
                            10.4.3.2. Financial performance
                            10.4.3.3. Product benchmarking
                            10.4.3.4. Strategic initiatives
                        10.4.4. Danaher Corporation
                            10.4.4.1. Company overview
                            10.4.4.2. Financial performance
                            10.4.4.3. Product benchmarking
                            10.4.4.4. Strategic initiatives
                        10.4.5. Thermo Fisher Scientific
                            10.4.5.1. Company overview
                            10.4.5.2. Financial performance
                            10.4.5.3. Product benchmarking
                            10.4.5.4. Strategic initiatives
                        10.4.6. Bio-Rad Laboratories
                            10.4.6.1. Company overview
                            10.4.6.2. Financial performance
                            10.4.6.3. Product benchmarking
                            10.4.6.4. Strategic initiatives
                        10.4.7. Beckman Coulter (a subsidiary of Danaher)
                            10.4.7.1. Company overview
                            10.4.7.2. Financial performance
                            10.4.7.3. Product benchmarking
                            10.4.7.4. Strategic initiatives
                        10.4.8. Sysmex Corporation
                            10.4.8.1. Company overview
                            10.4.8.2. Financial performance
                            10.4.8.3. Product benchmarking
                            10.4.8.4. Strategic initiatives
                        10.4.9. DiaSorin
                            10.4.9.1. Company overview
                            10.4.9.2. Financial performance
                            10.4.9.3. Product benchmarking
                            10.4.9.4. Strategic initiatives
                        10.4.10. Agilent Technologies
                            10.4.10.1. Company overview
                            10.4.10.2. Financial performance
                            10.4.10.3. Product benchmarking
                            10.4.10.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. immunoassay market, by product, 2018 - 2030 (USD Million)
Table 3 U.S. immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 4 U.S. immunoassay market, by application, 2018 - 2030 (USD Million)
Table 5 U.S. immunoassay market, by end use, 2018 - 2030 (USD Million)
Table 6 U.S. immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 7 U.S. immunoassay market, by region, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. immunoassay market: Market outlook
Fig. 9 U.S. immunoassay competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 U.S. immunoassay market driver impact
Fig. 14 U.S. immunoassay market restraint impact
Fig. 15 U.S. immunoassay market: Product movement analysis
Fig. 16 U.S. immunoassay market: Product outlook and key takeaways
Fig. 17 Reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Elisa reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Rapid test reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Elispot reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Western blot reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Other reagents & kits market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Analyzers/Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Open ended systems market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Closed ended systems market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Software & services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 U.S. immunoassay Market: Technology movement Analysis
Fig. 28 U.S. immunoassay market: Technology outlook and key takeaways
Fig. 29 Radioimmunoassay (RIA) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Enzyme Immunoassays (EIA) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Chemiluminescence Immunoassays (CLIA) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Fluorescence Immunoassays (FIA) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Rapid test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 U.S. immunoassay market: Application movement analysis
Fig. 36 U.S. immunoassay market: Application outlook and key takeaways
Fig. 37 Therapeutic drug monitoring market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Endocrinology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Infectious disease testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Autoimmune diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 U.S. immunoassay market: End-use movement analysis
Fig. 45 U.S. immunoassay market: End-use outlook and key takeaways
Fig. 46 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Blood banks market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Clinical laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Pharmaceutical and biotech companies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Academic research centers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 U.S. immunoassay market: Specimen movement analysis
Fig. 53 U.S. immunoassay market: Specimen outlook and key takeaways
Fig. 54 Blood market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Saliva market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Urine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Other specimens market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 U.S. immunoassay market: Regional movement analysis
Fig. 59 U.S. immunoassay market: Regional outlook and key takeaways
Fig. 60 West market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)